Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Wegovy Cost is already seeing results
Wegovy Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.
Key Fact
Weight Method's compounded semaglutide program is $154/month ($1,848/year), all-inclusive, with no insurance required. Weight Method does not dispense brand-name Wegovy®. Wegovy is FDA-approved; compounded semaglutide is not FDA-approved.
Source: Weight Method pricing, February 2026
Wegovy's pricing at a retail pharmacy reflects Novo Nordisk's pricing for a weight-management-specific FDA-approved indication. The five-pen dose-escalation kit (0.25mg through 2.4mg) is priced uniformly regardless of dose, meaning patients pay the same retail price during the low-dose initiation phase as at the maintenance dose. The insurance landscape for Wegovy is fragmented. Some employers have proactively added anti-obesity medication coverage, recognizing the long-term healthcare implications. Others have explicitly excluded it. Medicare Part D does not cover Wegovy for weight loss. Medicaid coverage varies by state, with most states excluding anti-obesity drugs. For patients with commercial coverage, an annual deductible must typically be met before copay rates apply. Weight Method's $154/month compounded semaglutide pricing is a flat all-inclusive monthly fee. There is no deductible, no prior authorization period, and no annual formulary surprises. Compounded semaglutide is not FDA-approved.
Weight Method's compounded semaglutide program is a flat $154/month all-inclusive fee. Brand-name Wegovy purchased cash-pay at a retail pharmacy is set by Novo Nordisk and accumulates a much larger annual cash outlay for patients without coverage. The decision between them is not purely financial — Wegovy is FDA-approved (with the FDA review process that designation entails), while compounded semaglutide is not. Published clinical-trial outcomes describe brand-name Wegovy at the 2.4mg maintenance dose. Those outcomes were generated with the FDA-approved product and should not be assumed to apply to compounded semaglutide, which is not FDA-evaluated. Your provider can discuss what to expect from compounded therapy based on your individual clinical profile. Non-financial considerations matter too. Patients on the conventional pathway report 3-6 weeks from prescription to first dose, including prior authorization processing and pharmacy coordination. Weight Method patients typically begin treatment within days.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityCompounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
We offer the most affordable GLP-1 treatments. Starting at $199/month.
See PricingFree consultation. No commitment.